(Q40856017)

24 September 2017

1 reference

title

Tumor necrosis factor, its receptors and the connection with interleukin 1 and interleukin 6. (English)

1 reference

24 September 2017

Brouckaert P

1

1 reference

24 September 2017

Libert C

2

1 reference

24 September 2017

Everaerdt B

3

1 reference

24 September 2017

Takahashi N

4

1 reference

24 September 2017

Cauwels A

5

1 reference

24 September 2017

Fiers W

6

1 reference

24 September 2017

publication date

1 April 1993

1 reference

24 September 2017

1 reference

24 September 2017

volume

187

1 reference

24 September 2017

issue

3-5

1 reference

24 September 2017

page(s)

317-329

1 reference

24 September 2017

cites work

Tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980347-5

7 January 2021

The metabolic effects of tumor necrosis factor and other cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980347-5

7 January 2021

The pathophysiology of tumor necrosis factors

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980347-5

7 January 2021

Endotoxin-responsive sequences control cachectin/tumor necrosis factor biosynthesis at the translational level

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980347-5

7 January 2021

NG-methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: implications for the involvement of nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980347-5

7 January 2021

Cachectin/TNF and IL-1 induced by glucose-modified proteins: role in normal tissue remodeling

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980347-5

7 January 2021

High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980347-5

7 January 2021

Effect of intraperitoneal recombinant human tumour necrosis factor alpha on malignant ascites

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980347-5

7 January 2021

Clinical studies with TNF.

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980347-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980347-5

1 reference

7 January 2021

Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980347-5

7 January 2021

Recombinant tumor necrosis factor: species specificity for a variety of human and murine transformed cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980347-5

7 January 2021

Recombinant tumor necrosis factor can induce interleukin 2 receptor expression and cytolytic activity in a rat x mouse T cell hybrid.

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980347-5

7 January 2021

Tumor necrosis factor alpha/cachectin is a growth factor for thymocytes. Synergistic interactions with other cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980347-5

7 January 2021

The two different receptors for tumor necrosis factor mediate distinct cellular responses

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980347-5

7 January 2021

Functional characterization of the human tumor necrosis factor receptor p75 in a transfected rat/mouse T cell hybridoma

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980347-5

7 January 2021

The p70 tumor necrosis factor receptor mediates cytotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980347-5

7 January 2021

In vivo anti-tumour activity of recombinant human and murine TNF, alone and in combination with murine IFN-gamma, on a syngeneic murine melanoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980347-5

7 January 2021

Four different interleukin-1 species sensitize to the lethal action of tumour necrosis factor.

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980347-5

7 January 2021

The glucocorticoid antagonist RU38486 mimics interleukin-1 in its sensitization to the lethal and interleukin-6-inducing properties of tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980347-5

7 January 2021

A recombinant human receptor antagonist to interleukin 1 improves survival after lethal endotoxemia in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980347-5

7 January 2021

The IL-6 signal transducer, gp130: an oncostatin M receptor and affinity converter for the LIF receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980347-5

7 January 2021

Induction of interleukin 6 by human and murine recombinant interleukin 1 in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980347-5

7 January 2021

Circulating interleukin 6 during a continuous infusion of tumor necrosis factor and interferon gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980347-5

7 January 2021

Limited involvement of interleukin-6 in the pathogenesis of lethal septic shock as revealed by the effect of monoclonal antibodies against interleukin-6 or its receptor in various murine models

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980347-5

7 January 2021

10.1016/S0171-2985(11)80347-5

Identifiers

DOI

0 references

1 reference